Robert Klamroth Selected Research

BAX 855

1/2021	Rurioctocog alfa pegol PK-guided prophylaxis in hemophilia A: results from the phase 3 PROPEL study.
1/2019	Matching-adjusted indirect comparisons of annualized bleeding rate and utilization of BAY 94-9027 versus three recombinant factor VIII agents for prophylaxis in patients with severe hemophilia A.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Robert Klamroth Research Topics

Disease

30	Hemophilia A (Haemophilia) 03/2022 - 04/2009
24	Hemorrhage 03/2022 - 01/2007
8	Thrombosis (Thrombus) 01/2022 - 03/2008
5	Thrombocytopenia (Thrombopenia) 06/2021 - 01/2007
4	COVID-19 06/2021 - 06/2020
4	Hemophilia B (Haemophilia B) 01/2021 - 09/2012
3	von Willebrand Diseases (von Willebrand's Disease) 05/2014 - 01/2007
2	Neoplasms (Cancer) 01/2022 - 01/2019
2	Thrombotic Microangiopathies 05/2021 - 12/2020
2	Thrombophilia 01/2013 - 08/2012
2	Body Weight (Weight, Body) 08/2010 - 01/2007
1	Venous Thrombosis (Deep-Vein Thrombosis) 01/2022
1	Hematoma 06/2021
1	Idiopathic Thrombocytopenic Purpura (Thrombocytopenic Purpura, Autoimmune) 06/2021
1	Metrorrhagia (Spotting) 05/2021
1	Venous Thromboembolism 01/2019
1	Vomiting 01/2019
1	Necrosis 11/2017
1	Type 1 von Willebrand Disease 08/2013
1	Type 2 von Willebrand Disease 08/2013
1	Fistula 01/2013
1	Disseminated Intravascular Coagulation 01/2007
1	Disease Susceptibility (Diathesis) 01/2007
1	Factor VII Deficiency (Hypoproconvertinemia) 01/2007
1	Habitual Abortion (Recurrent Miscarriage) 05/2005
1	Obesity 05/2005

Drug/Important Bio-Agent (IBA)

21	Factor VIII (Coagulation Factor VIII)IBA 06/2021 - 04/2009
6	emicizumabIBA 03/2022 - 08/2017
6	AnticoagulantsIBA 01/2022 - 08/2012
5	Hemostatics (Antihemorrhagics)IBA 02/2022 - 02/2015
4	AntibodiesIBA 03/2022 - 05/2005
4	recombinant factor VIII N8IBA 02/2022 - 01/2020
4	Factor IX (Coagulation Factor IX)FDA LinkGeneric 06/2021 - 09/2012
4	Heparin (Liquaemin)FDA LinkGeneric 06/2021 - 03/2008
4	Proteins (Proteins, Gene)FDA Link 01/2021 - 08/2012
3	Blood Coagulation Factors (Coagulation Factor)IBA 03/2022 - 01/2007
3	VaccinesIBA 06/2021 - 06/2021
3	Prothrombin (Factor II)IBA 05/2021 - 05/2005
3	AutoantibodiesIBA 01/2020 - 04/2009
3	AntithrombinsIBA 08/2012 - 05/2005
2	BAX 855IBA 01/2021 - 01/2019
2	factor IX Fc fusion proteinIBA 01/2021 - 04/2019
2	AlbuminsIBA 01/2021 - 09/2012
2	factor VIII-Fc fusion proteinIBA 01/2021 - 01/2016
2	BAY 94-9027IBA 01/2021 - 01/2019
2	6-pyruvoyltetrahydropterin synthase (PTPS)IBA 01/2020 - 01/2019
2	Serum AlbuminIBA 01/2019 - 05/2013
2	Factor IXa (Coagulation Factor IXa)IBA 01/2019 - 08/2017
2	Fondaparinux (Arixtra)FDA Link 11/2017 - 07/2014
2	von Willebrand FactorIBA 08/2013 - 08/2013
2	Protein SIBA 08/2012 - 05/2005
2	Protein CIBA 08/2012 - 05/2005
1	COVID-19 VaccinesIBA 06/2021
1	ChAdOx1 nCoV-19IBA 06/2021
1	Indicators and Reagents (Reagents)IBA 01/2021
1	prothrombin complex concentrates (PPSB)IBA 01/2020
1	nonacog beta pegolIBA 04/2019
1	Vitamin K FDA Link 01/2019
1	N(4)-oleylcytosine arabinosideIBA 01/2019
1	simoctocog alfa (Nuwiq)IBA 01/2019
1	Coenzymes (Enzyme Cofactors)IBA 01/2019
1	CoagulantsIBA 01/2019
1	LigandsIBA 01/2019
1	Thrombin FDA Link 01/2019
1	lepirudin (Refludan)FDA Link 11/2017
1	argatroban (MPQA)FDA Link 11/2017
1	danaparoid (Orgaran)FDA Link 11/2017
1	Immunoglobulin G (IgG)IBA 08/2017
1	Factor X (Stuart Factor)IBA 08/2017
1	Neutralizing AntibodiesIBA 09/2013
1	Polytetrafluoroethylene (Teflon)FDA Link 01/2013
1	Human Serum Albumin FDA LinkGeneric 09/2012
1	Recombinant Fusion ProteinsIBA 09/2012
1	Phenprocoumon (Liquamar)FDA Link 08/2010
1	Enoxaparin (Lovenox)FDA LinkGeneric 08/2010
1	SteroidsIBA 04/2009
1	Rituximab (Mabthera)FDA Link 04/2009
1	Pharmaceutical PreparationsIBA 01/2007
1	recombinant FVIIa (rFVIIa)FDA Link 01/2007
1	Plasminogen InactivatorsIBA 05/2005
1	Factor V (Coagulation Factor V)IBA 05/2005
1	Lipoprotein(a)IBA 05/2005

Therapy/Procedure

10	Therapeutics 03/2022 - 01/2007
2	Injections 05/2019 - 01/2007
1	Secondary Prevention 01/2022
1	Radiotherapy 01/2022
1	Intramuscular Injections 06/2021
1	Blood Transfusion (Blood Transfusions) 01/2021
1	Surgical Amputation (Amputations) 11/2017
1	Intravenous Injections 08/2017
1	Replacement Arthroplasty 11/2014
1	Cholecystectomy 11/2014
1	Off-Label Use 07/2014
1	Renal Dialysis (Hemodialysis) 01/2013